A feasibility randomised controlled trial of short-term fasting prior to CAPOX chemotherapy for stage 2/3 colorectal cancer: SWiFT protocol

BACKGROUND: Capecitabine and oxaliplatin (CAPOX) chemotherapy is a standard treatment for stage 2/3 colorectal cancer. Treatment is associated with dose-limiting toxicities such as neutropenia, vomiting, diarrhoea, and stomatitis. Short-term fasting prior to chemotherapy may help protect normal cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Shingler, Ellie, Perks, Claire, Herbert, Georgia, Ness, Andy, Atkinson, Charlotte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6868731/
https://www.ncbi.nlm.nih.gov/pubmed/31832229
http://dx.doi.org/10.1186/s40814-019-0505-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6868731/
https://www.ncbi.nlm.nih.gov/pubmed/31832229
http://dx.doi.org/10.1186/s40814-019-0505-7

Ejemplares similares